This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...

Drug companies have cut nearly 69,000 pharmaceutical jobs since the start of 2021. A single biotech job posting now attracts ...

Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

The biotechnology industry is nearly as old as the personal computer, but it lacks a Steve Jobs-like figure that the broader ...

Angelica Peebles, CNBC Health and Pharmaceutical Reporter, says U.S. drugmakers are accelerating China partnerships as ...

ZYCUBO® approved by FDA to treat Menkes disease in the United States; Fortress subsidiary Cyprium Therapeutics closed the sale of its Rare ...

Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a once-highly touted ...

Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs ...

A Boston biotechnology company that abandoned plans to go public last year completed a successful initial public offering earlier this month — raising $279 million in a deal that signals renewed ...

Top 10 mid-cap stocks by YTD performance amid market volatility—see 600%+ gainers across semis, biotech & more, plus mid-cap ...